Emerald Health (EMHTF) is very well positioned. Although we currently think that the mass of private consumers will bring in the big money – IMO on the long run it will be earned in the scientifical, medical field. Serving the mass demand is a purely economic-organizational diligence task. The medical field is the scientific part, it has something to do with knowledge and that is THE unique feature or unique selling proposition of a company. Patents make it easier to stand out from the competition, than through a perpetual price war. https://finance.yahoo.com/news/emerald-health-pharmaceuticals-present-sachs-080000443.html